Marine [omega]-3 Fatty Acid Intake

• Autores: L. María Belalcázar, David M. Reboussin, Steven M. Haffner, Rebecca S. Reeves, Dawn C. Schwenke, Ron C Hoogeveen, Francesc-Xavier Pi-Sunyer, Christie M Ballantyne
• Localización: Diabetes care, ISSN-e 0149-5992, Vol. 33, Nº. 1 (ENE), 2010, págs. 197-199
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • To examine usual marine ù-3 fatty acid (mO-3FA) intake in individuals with diabetes; its association with adiposity, lipid, and glucose control; and its changes with behavioral lifestyle intervention for weight loss. Cross-sectional and 1-year longitudinal analyses were performed on 2, 397 Look AHEAD (Action for Health in Diabetes) participants. Look AHEAD is a cardiovascular outcome trial evaluating the effects of intensive lifestyle intervention for weight loss in overweight/obese subjects with type 2 diabetes. Baseline mO-3FA intake was 162 ± 138 mg/day. It was inversely associated with triglycerides (â = -0.41, P < 0.001) and weakly with HDL (â = 4.14, P = 0.050), after multiple covariate adjustment. One-year mO-3FA and fried/sandwich fish intake decreased with intensive lifestyle intervention (P < 0.001). MO-3FA intake in Look AHEAD participants was low but associated favorably with lipids. These results encourage investigation on the potential benefits of increasing mO-3FA intake in lifestyle interventions for weight loss in individuals with diabetes.